InMed Pharmaceuticals Inc. (INM)
NASDAQ: INM · Real-Time Price · USD
1.360
-0.015 (-1.09%)
At close: Sep 30, 2026, 4:00 PM EDT
1.360
0.00 (0.00%)
Pre-market: Oct 1, 2026, 4:02 AM EDT
Company Description
InMed Pharmaceuticals Inc. operates as a pharmaceutical drug development company in the United States.
The company researches and develops cannabinoid-based pharmaceuticals products. Its product candidates include INM-901 for Alzheimer’s disease, INM-089 for dry age-related macular degeneration, and INM-755, a cannabinol cream.
The company was formerly known as Cannabis Technologies Inc. and changed its name to InMed Pharmaceuticals Inc. in October 2014.
InMed Pharmaceuticals Inc. was incorporated in 1981 and is based in Vancouver, Canada.
InMed Pharmaceuticals Inc.
| Country | Canada |
| Founded | 1981 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 6 |
| CEO | Eric Adams |
Contact Details
Address: 500 West Georgia Street, Suite 1800 Vancouver, BC V6B 0M3 Canada | |
| Phone | 604 669 7207 |
| Website | inmedpharma.com |
Stock Details
| Ticker Symbol | INM |
| Exchange | NASDAQ |
| Fiscal Year | July - June |
| Reporting Currency | USD |
| CIK Code | 1728328 |
| CUSIP Number | 457637700 |
| ISIN Number | CA4576377002 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Eric A. Adams B.S. Chem., M.I.B. | President, Chief Executive Officer and Director |
| N. Netta Jagpal | Chief Financial Officer and Corporate Secretary |
| Michael Woudenberg P.Eng. | Chief Operating Officer |
| Dr. Eric Chih-Hsien Hsu Ph.D. | Senior Vice President of Preclinical Research and Development |
| Dr. Sazzad Hossain M.Sc., Ph.D. | Co-Founder |
| Colin Clancy | Vice President of Investor Relations and Corporate Communications |
| Jerry P. Griffin | Vice President of Sales and Marketing |
| Dr. Shane A. Johnson Ph.D. | Senior Vice President and GM of BayMedica |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Sep 29, 2026 | S-4/A | Filing |
| Sep 18, 2026 | 8-K | Current Report |
| Sep 9, 2026 | S-4/A | Filing |
| Sep 9, 2026 | 425 | Filing |
| Sep 9, 2026 | 10-K | Annual Report |
| Aug 14, 2026 | SCHEDULE 13G | Filing |
| Jul 22, 2026 | 425 | Filing |
| Jul 22, 2026 | 425 | Filing |
| Jul 22, 2026 | 8-K | Current Report |
| Jul 20, 2026 | 425 | Filing |